ArticleBriefings in bioinformatics2025
Deep graph convolutional network-based multi-omics integration for cancer driver gene identification.
Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Disentangling Heterogeneous Molecular Networks for Multi-Omics-Driven Cancer Driver Discovery.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Decoding disease and therapy through multiomics integration and systems analysis.Briefings in bioinformatics · 2026Review
- Multiplex networks-based directed graph neural network for cancer driver gene identification.PLoS computational biology · 2026Article
- M-GNN: A Topology-Enhanced Multi-Modal Graph Neural Network for Cancer Driver Gene Prediction.Metabolites · 2026Article
- Deep Learning-Enabled Multi-Omics Integration: A New Frontier in Precise Drug Target Discovery.Biology · 2026Review
- Artificial intelligence-driven drug discovery: a deep learning paradigm shift in pharmaceutical research and development.Frontiers in pharmacology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Cancer driver genes play a pivotal role in understanding cancer development, progression, and therapeutic discovery. The plenty of accumulation of multi-omics data and biological networks provides a data foundation for graph neural network (GNN) frameworks. However, most existing methods directly concatenate multi-omics data as features, which may lead to limited performance. To address this limitation, we propose deepCDG, a deep graph convolutional network (GCN)-based multi-omics integration model for cancer driver gene identification. The model first employs shared-parameter GCN encoders to extract representations from three omics perspectives, followed by feature integration through an attention layer, and finally utilizes a residual-connected GCN predictor for cancer driver gene identification. Additionally, deepCDG employs GNNExplainer for cancer driver gene module identification. Experimental results demonstrate the effective predictive performance, model robustness, and computational efficiency of deepCDG. Additionally, biological interpretability analysis further validates the reliability of the identification of cancer driver genes of our framework, and the identified gene modules provide profound insights into complex inter-gene relationships and interactions. We believe our method offers enhanced applicability for cancer driver gene identification and could be extended to other biological research fields in future studies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.